Evidence map›Paper›PMID 25853299›Full record

ArticleEuropean journal of human genetics : EJHG2015

A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.

Reymundo Lozano, Arianna Vino, Cristina Lozano, Simon E Fisher, Pelagia Deriziotis

Abstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Case report: Expanding the phenotype ofFrontiers in neurology · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Regulatory genes and pathways disrupted in autism spectrum disorders.Progress in neuro-psychopharmacology & biological psychiatry · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Foxp1 in Forebrain Pyramidal Neurons Controls Gene Expression Required for Spatial Learning and Synaptic Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reymundo LozanoMedical Investigation of Neurodevelopmental Disorders (MIND) Institute, Department of Pediatrics, UC Davis Medical Center, Sacramento, CA, USA.
Arianna VinoLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
Cristina LozanoMedical Investigation of Neurodevelopmental Disorders (MIND) Institute, Department of Pediatrics, UC Davis Medical Center, Sacramento, CA, USA.
Simon E FisherLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
Pelagia DeriziotisLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Funding

GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
T32 training grant in medical genetics.T32GM082773 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Laszlo Tamas Kozicz, Eva Morava-Kozicz · 2008 to 2026
$4.9M
INVESTIGATOR DEVELOPMENT COREP30AG043097 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HINTON, WALTER LADSON · 2012 to 2017
$2.9M
NIA NIH HHS P30 AG043097NIA NIH HHS P30AG043097NICHD NIH HHS HD036071NICHD NIH HHS R01 HD036071NIGMS NIH HHS T32 GM082773
6 · The paper itself

Abstract

FOXP1 (forkhead box protein P1) is a transcription factor involved in the development of several tissues, including the brain. An emerging phenotype of patients with protein-disrupting FOXP1 variants includes global developmental delay, intellectual disability and mild to severe speech/language deficits. We report on a female child with a history of severe hypotonia, autism spectrum disorder and mild intellectual disability with severe speech/language impairment. Clinical exome sequencing identified a heterozygous de novo FOXP1 variant c.1267_1268delGT (p.V423Hfs*37). Functional analyses using cellular models show that the variant disrupts multiple aspects of FOXP1 activity, including subcellular localization and transcriptional repression properties. Our findings highlight the importance of performing functional characterization to help uncover the biological significance of variants identified by genomics approaches, thereby providing insight into pathways underlying complex neurodevelopmental disorders. Moreover, our data support the hypothesis that de novo variants represent significant causal factors in severe sporadic disorders and extend the phenotype seen in individuals with FOXP1 haploinsufficiency.

Indexed as

MutationAdolescentAutistic DisorderFemaleForkhead Transcription FactorsHEK293 CellsHumansIntellectual DisabilityLanguage DisordersProtein TransportRepressor ProteinsSyndromeForkhead Transcription FactorsFOXP1 protein, humanRepressor Proteins

Identifiers

PMID25853299
PMCPMC4795189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.